ALBIREO PHARMA, INC. Chart calendar Albireo Pharma, Inc.
9fd830c.pta48_V3KZnVIqQ8rJ1PMNSNAUzd0ADYS38hN5RHsZM.lqDnp6IicN-tc_FIy8cqApa7YzmRsTatZiVEUfki-f35p4ymlEdZw6RG7Q~9b7f648e0f439160f1d1a75d87424b97
Upcoming events on Albireo Pharma, Inc.
No events available
Past events on Albireo Pharma, Inc.
| 15/11/2022 03:50 pm | Jefferies London Healthcare Conference |
| 09/11/2022 03:00 am | Q3 2022 Earnings Call |
| 08/11/2022 | Q3 2022 Earnings Release After hours |
| 07/11/2022 11:30 pm | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37254 |
| 07/11/2022 11:30 pm | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37608 |
| 07/11/2022 11:30 pm | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 850 |
| 07/11/2022 11:30 pm | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37939 |
| 07/11/2022 11:30 pm | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37273 |
| 07/11/2022 12:40 am | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 865 |
| 06/11/2022 11:30 pm | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Meeting : 37733 |
| 18/10/2022 08:00 pm | H.C. Wainwright Hepatitis B Virus (HBV) Conference |
| 15/10/2022 11:30 pm | NASPGHAN Meeting |
| 15/10/2022 09:30 pm | NASPGHAN Meeting - Abstract Number : 547 |
| 14/10/2022 11:15 pm | NASPGHAN Meeting |
| 14/10/2022 09:30 pm | NASPGHAN Meeting - Abstract Number : 301 |
| 14/10/2022 02:30 am | NASPGHAN Meeting - Abstract Number : 70 |
| 11/10/2022 06:00 pm | Bylvay Phase 3 Trial Results Call |
| 28/09/2022 06:00 pm | Guggenheim Therapeutics Conference |
| 13/09/2022 06:00 pm | Baird Global Healthcare Conference |
| 12/09/2022 08:00 pm | Morgan Stanley Global Healthcare Conference |
More events
